06-06-2013 • Fox News
When
patients are diagnosed with multiple sclerosis, their bodies begin to
attack the protein myelin, which insulates the body’s spinal cord, brain
and optic nerves. As a result, MS patients experience symptoms such as
numbness in their limbs, paralysis and sometimes blindness.
However, during a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body’s attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
Current treatments for MS seek to lessen the body’s autoimmune response to myelin, but this often results in decreased effectiveness of the entire immune system.
Read Full StoryHowever, during a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body’s attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
Current treatments for MS seek to lessen the body’s autoimmune response to myelin, but this often results in decreased effectiveness of the entire immune system.
Reported by Robert Lee
No comments:
Post a Comment